Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 47%
Hold 18%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is well-positioned in the healthcare industry, with a strong PBM and specialty pharmacy services segment that serves both insurance plans and employers. The recent merger with Express Scripts and new contracts with top-tier insurers, such as Centene, highlight the company's momentum and potential for growth. Additionally, its commitment to exiting the Exchange market and strategic review of its prior authorization unit show a focus on core growth opportunities. Despite potential economic impacts, Cigna's recent earnings beat and raised guidance indicate a positive outlook for the company's future performance.

Bears say

Cigna Group is facing headwinds in their PBM and health insurance services due to higher utilization and rate headwinds in the Medicare Advantage market. While the company is implementing measures to strengthen margins and has seen growth in its commercial membership, there are concerns around execution risk in managing medical cost trends and potential impact from regulatory changes on rebate economics. Additionally, the lack of a clear catalyst may limit market appetite for the stock, but the company's announcement of a September 2026 I-Day could reignite interest. The company's AI risk prediction model has shown early success in identifying complex patients and reducing unnecessary visits, but it remains to be seen if this can sustainably impact the company's bottom line. Overall, market conditions and potential risks make us maintain a negative outlook on Cigna Group's stock for the near future.

Cigna (CI) has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 47% recommend Buy, 18% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 17 analysts, Cigna (CI) has a Buy consensus rating as of Jun 26, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $345, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $345, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.